GB CL CEA
GB CL CEA is a quantitative CL kit for measuring CEA in serum/plasma. Supports early colorectal cancer diagnosis and relapse monitoring with rapid 10-minute assay. TFDA certified.
PRODUCT DESCRIPTION
This in vitro diagnostic kit uses a quantitative chemiluminescent immunoassay (CL) sandwich format to measure carcinoembryonic antigen (CEA) in human serum or plasma. Requires 30 µL sample, with a rapid 10-minute assay. LoQ is 0.32 ng/mL. Stored at 2-8°C, protected from light. TFDA certified. Ideal for colorectal cancer diagnostics and monitoring disease progression or recurrence.
PERFORMANCE
| Limit of Quantitation (LoQ): 0.32 ng/mL | ||
|---|---|---|
| Precision | Variability | Coefficient of variation, CV (%) |
| Repeatability | within run | <10% |
| Reproducibility | between-run/between-day | <10% |
| between-sites/between-operators | <10% | |
| between-lots | <10% | |
SPECIFICATION
| Principle | Sandwich-type chemiluminescent immunoassay |
| Assay format | Quantification |
| Rreaction time | 10 minutes |
| Sample type | Serum/Plasma |
| Sample volume | 30 μL |
| Detection unit | Relative light unit (RLU) |
| Storage | 2-8°C. Avoid exposure to direct sunlight. Do not freeze. |
| Certification | TFDA |
ORDERING INFORMATION
| Catalogue No. | Product |
|---|---|
| 4ACEA02 | GB CL CEA |
| 4ACEA1B | GB CL CEA-Control |
| 4ACEA2B | GB CL CEA-Calibrator |